Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F10%3A10062300" target="_blank" >RIV/00216208:11150/10:10062300 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00179906:_____/10:10062300
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features
Popis výsledku v původním jazyce
Elevated expression of angiopoietin-2 (Ang-2), was recently reported in CLL. We quantitated Ang-2 mRNA in purified mononuclear cells of 33 untreated CLL patients and compared the transcript levels to traditional as well as modern prognostic factors in patients with CLL. Elevated Ang-2 mRNA concentrations were detected in 12 cases; 21 patients had very low or undetectable levels of Ang-2 transcript. There was significant association between high Ang-2 mRNA levels and unmutated IgVH genes (n=27, P=0.010)and with CD38 expression (n=32, P=0.011), but not with ZAP-70 expression (n=32,P=0.784), Rai stage (n=33, P=0.305) or stable versus progressive clinical course (n=33,P=0.443). There was a trend towards shorter progression-free survival in patients with high Ang-2 expression; however, it did not reach statistical significance (P=0.090). Our pilot data show that Ang-2 mRNA is differentially expressed in patients with CLL and its increased expression appears to be associated with poor progn
Název v anglickém jazyce
Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features
Popis výsledku anglicky
Elevated expression of angiopoietin-2 (Ang-2), was recently reported in CLL. We quantitated Ang-2 mRNA in purified mononuclear cells of 33 untreated CLL patients and compared the transcript levels to traditional as well as modern prognostic factors in patients with CLL. Elevated Ang-2 mRNA concentrations were detected in 12 cases; 21 patients had very low or undetectable levels of Ang-2 transcript. There was significant association between high Ang-2 mRNA levels and unmutated IgVH genes (n=27, P=0.010)and with CD38 expression (n=32, P=0.011), but not with ZAP-70 expression (n=32,P=0.784), Rai stage (n=33, P=0.305) or stable versus progressive clinical course (n=33,P=0.443). There was a trend towards shorter progression-free survival in patients with high Ang-2 expression; however, it did not reach statistical significance (P=0.090). Our pilot data show that Ang-2 mRNA is differentially expressed in patients with CLL and its increased expression appears to be associated with poor progn
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
Z - Vyzkumny zamer (s odkazem do CEZ)
Ostatní
Rok uplatnění
2010
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Hematology
ISSN
1024-5332
e-ISSN
—
Svazek periodika
15
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
5
Strana od-do
—
Kód UT WoS článku
000280648600004
EID výsledku v databázi Scopus
—